Bases bibliographiques Pascal et Francis

Aide

Résultats de votre recherche

Votre recherche

ct.\*:("Hypnotiques. Sédatifs")

Filtre

A-Z Z-A Fréquence ↓ Fréquence ↑
Export CSV

Type de document [dt]

A-Z Z-A Fréquence ↓ Fréquence ↑
Export CSV

Année de publication [py]

A-Z Z-A Fréquence ↓ Fréquence ↑
Export CSV

Discipline (document) [di]

A-Z Z-A Fréquence ↓ Fréquence ↑
Export CSV

Langue

A-Z Z-A Fréquence ↓ Fréquence ↑
Export CSV

Pays auteur

A-Z Z-A Fréquence ↓ Fréquence ↑
Export CSV

Résultats 1 à 25 sur 3280

  • Page / 132
Export

Sélection :

  • et

Tasimeltéon pour traiter le syndrome de retard de phase du sommeil = Tasimelteon for non-24-hour sleep-wake disorderThe Medical letter on drugs and therapeutics (Edition française). 2014, Vol 36, Num 11, pp 45-46, issn 0253-8512, 2 p.Article

Suvorexant: First Global ApprovalYANG, Lily P. H.Drugs (Basel). 2014, Vol 74, Num 15, pp 1817-1822, issn 0012-6667, 6 p.Article

Clinical and Economic Impact of Substituting Dexmedetomidine for Propofol due to a US Drug Shortage: Examination of Coronary Artery Bypass Graft Patients at an Urban Medical CentreTHOMA, Brandi N; LI, Julius; MCDANIEL, Cara M et al.PharmacoEconomics (Auckland). 2014, Vol 32, Num 2, pp 149-157, issn 1170-7690, 9 p.Article

The acute cognitive effects of zopiclone, zolpidem, zaleplon, and eszopiclone: A systematic review and meta-analysisSTRANKS, Elizabeth K; CROWE, Simon F.Neuropsychology, development, and cognition. Section A, journal of clinical and experimental neuropsychology. 2014, Vol 36, Num 7-8, pp 691-700, issn 1380-3395, 10 p.Article

La FDA demande une posologie plus faible pour le zolpidem = FDA requires lower dosing of ZolpidemThe Medical letter on drugs and therapeutics (Edition française). 2013, Vol 35, Num 4, issn 0253-8512, p. 14Article

Validity and generalizability of the Withdrawal Assessment Tool-1 (WAT-1) for monitoring iatrogenic withdrawal syndrome in pediatric patientsFRANCK, LindaS; SCOPPETTUOLO, LisaA; WYPIJB, David et al.Pain (Amsterdam). 2012, Vol 153, Num 1, pp 142-148, issn 0304-3959, 7 p.Article

L'activité de pharmacie clinique en hospitalisation continue d'oncologie et d'hématologie améliore significativement l'efficacité des actions pharmaceutiques et la prévention des problèmes pharmacothérapeutiques = Clinical pharmacist activity in an oncology and haematology unit significantly improves and secure patient careTANGUY-GOARIN, C; MUGNIER, N.Le Pharmacien hospitalier. 2011, Vol 46, Num 1, pp 4-12, issn 0768-9179, 9 p.Article

Adult age and ex vivo protein binding of lorazepam, oxazepam and temazepam in healthy subjectsCHIN, Paul K. L; JENSEN, Berit P; LARSEN, Helle S et al.British journal of clinical pharmacology. 2011, Vol 72, Num 6, pp 985-989, issn 0306-5251, 5 p.Article

Spectroscopic studies on the binding of barbital to bovine serum albuminFEI DING; HONG PAN; LI, Zhi-Yuan et al.Journal of luminescence. 2009, Vol 129, Num 6, pp 650-655, issn 0022-2313, 6 p.Article

Efficacy and Safety of Doxepin 1 mg, 3 mg, and 6 mg in Elderly Patients With Primary Insomnia : A Randomized, Double-Blind, Placebo-Controlled Crossover StudySCHARF, Martin; ROGOWSKI, Roberta; HULL, Steven et al.The Journal of clinical psychiatry. 2008, Vol 69, Num 10, pp 1557-1564, issn 0160-6689, 8 p.Article

Hypnotic Discontinuation in Chronic Insomnia : Impact of Psychological Distress, Readiness to Change, and Self-EfficacyBELLEVILLE, Geneviève; MORIN, Charles M.Health psychology (Hillsdale, N.J.). 2008, Vol 27, Num 2, pp 239-248, issn 0278-6133, 10 p.Article

Nonnightmare Distressed Awakenings in Veterans With Posttraumatic Stress Disorder : Response to PrazosinTHOMPSON, Charles E; TAYLOR, Fletcher B; MCFALL, Miles E et al.Journal of traumatic stress. 2008, Vol 21, Num 4, pp 417-420, issn 0894-9867, 4 p.Article

Synthesis and CNS depressant activity of some novel 3-[5-substituted 1,3,4-thiadiazole-2-yl]-2-styryl quinazoline-4(3// )-onesJATAV, Varsha; MISHRA, Pradeep; KASHAW, Sushil et al.European journal of medicinal chemistry. 2008, Vol 43, Num 1, pp 135-141, issn 0223-5234, 7 p.Article

En bref - Diminution de la dose d'eszopiclone = In brief: lowering the dose of eszopicloneThe Medical letter on drugs and therapeutics (Edition française). 2014, Vol 36, Num 14, issn 0253-8512, p. 57Article

Stability of dexmedetomidine in polyvinyl chloride bags containing 0.9% sodium chloride injectionPRESLASKI, Candice R; MUELLER, Scott W; WEMPE, Michael F et al.American journal of health-system pharmacy. 2013, Vol 70, Num 15, pp 1336-1341, issn 1079-2082, 6 p.Article

The glycolytic metabolite methylglyoxal induces changes in vigilance by generating low-amplitude non-REM sleepJAKUBCAKOVA, Vladimira; CURZI, M. Letizia; FLACHSKAMM, Cornelia et al.Journal of psychopharmacology (Oxford). 2013, Vol 27, Num 11, pp 1070-1075, issn 0269-8811, 6 p.Article

Synthesis, hypnotic properties and molecular modeling studies of 1,2,7,9-tetraaza-spiro[4.5]dec-2-ene-6,8,10-trionesGIRGIS, Adel S; FARAG, Hanaa; ISMAIL, Nasser S. M et al.European journal of medicinal chemistry. 2011, Vol 46, Num 10, pp 4964-4969, issn 0223-5234, 6 p.Article

Effets paradoxaux du zolpidem : Vingt-neuvièmes journées françaises de pharmacovigilance : les faits marquants = Improvement of akinetic mutism after chronic administration of zolpidemLa Revue Prescrire. 2008, Vol 28, Num 301, pp 831-831, issn 0247-7750, 1 p.Article

Dexmedetomidine and the Reduction of Postoperative Delirium after Cardiac SurgeryMALDONADO, José R; WYSONG, Ashley; VAN DER STARRE, Pieter J. A et al.Psychosomatics (Washington, DC). 2009, Vol 50, Num 3, pp 206-217, issn 0033-3182, 12 p.Article

Sedative Load and Mortality among Residents of Long-Term Care Facilities: A Prospective Cohort StudyTAIPALE, Heidi T; SIMON BELL, J; SOINI, Helena et al.Drugs & aging. 2009, Vol 26, Num 10, pp 871-881, issn 1170-229X, 11 p.Article

Nouvelle formulation de zolpidem = A new sublingual formulation of zolpidem (Edluar)The Medical letter on drugs and therapeutics (Edition française). 2010, Vol 32, Num 10, pp 37-38, issn 0253-8512, 2 p.Article

Identification of a novel selective H1-antihistamine with optimized pharmacokinetic properties for clinical evaluation in the treatment of insomniaMOREE, Wilna J; LI, Bin-Feng; HERNANDEZ, Lisa M et al.Bioorganic & medicinal chemistry letters (Print). 2010, Vol 20, Num 19, pp 5874-5878, issn 0960-894X, 5 p.Article

Novel imidazobenzazepine derivatives as dual H1/5-HT2A antagonists for the treatment of sleep disordersGIANOTTI, Massimo; CORTI, Corrado; DELLE FRATTE, Sonia et al.Bioorganic & medicinal chemistry letters (Print). 2010, Vol 20, Num 17, pp 5069-5073, issn 0960-894X, 5 p.Article

The use of melatonin to treat sleep disorder in adults with intellectual disabilities in community settings -the evaluation of three cases using actigraphyDODD, A; HARE, D. J; ARSHAD, P et al.JIDR. Journal of intellectual disability research (Print). 2008, Vol 52, pp 547-553, issn 0964-2633, 7 p., 6Article

A physiologic basis for the evolution of pharmacotherapy for insomniaROTH, Thomas.The Journal of clinical psychiatry. Supplement. 2007, Vol 68, Num 5, pp 13-18, 6 p.Conference Paper

  • Page / 132